VisiVite plans launch of macular health supplement

VisiVite will release ProVision, a macular health formula based on the AREDS 2 study, this spring, according to a press release from the company.

ProVision will include vitamin C 500 mg, vitamin E 400 IU, zinc 25 mg, copper 1 mg, lutein 10 mg and zeaxanthin 2 mg.

The supplement will be exclusively available from eye health providers, the company said.

"With ProVision, eye doctors get the simplicity of recommending an affordable, doctor-formulated AREDS 2 macular health supplement made by VisiVite," Paul Krawitz, MD, CEO of Vitamin Science Inc., said in the release. "Patients get an evidence-based means of supporting their vision that's affordable and easy to take: Just two easy-to-swallow softgels daily supply therapeutic antioxidant levels, and a single bottle lasts 90 days so patients only need to buy it four times per year."

ProVision will launch at Vision Expo East in New York in March. As detailed in the release, it will be available in demi-cases of 12 bottles.

VisiVite will release ProVision, a macular health formula based on the AREDS 2 study, this spring, according to a press release from the company.

ProVision will include vitamin C 500 mg, vitamin E 400 IU, zinc 25 mg, copper 1 mg, lutein 10 mg and zeaxanthin 2 mg.

The supplement will be exclusively available from eye health providers, the company said.

"With ProVision, eye doctors get the simplicity of recommending an affordable, doctor-formulated AREDS 2 macular health supplement made by VisiVite," Paul Krawitz, MD, CEO of Vitamin Science Inc., said in the release. "Patients get an evidence-based means of supporting their vision that's affordable and easy to take: Just two easy-to-swallow softgels daily supply therapeutic antioxidant levels, and a single bottle lasts 90 days so patients only need to buy it four times per year."

ProVision will launch at Vision Expo East in New York in March. As detailed in the release, it will be available in demi-cases of 12 bottles.